Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
1.560
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.570
+0.010 (0.63%)
After-hours: Apr 28, 2026, 7:43 PM EDT
Filana Therapeutics Employees
As of December 31, 2025, Filana Therapeutics had 20 total employees, including 17 full-time and 3 part-time employees. The number of employees decreased by 10 or -33.33% compared to the previous year.
Employees
20
Change (1Y)
-10
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$4,548,650
Market Cap
75.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| XBiotech | 85 |
| Fortress Biotech | 78 |
| Acrivon Therapeutics | 76 |
| ImmuCell | 73 |
| aTyr Pharma | 60 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
| LeonaBio | 19 |
FLNA News
- 2 months ago - Cassava Sciences says US DOJ has closed investigation into company - Reuters
- 4 months ago - HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 4 months ago - FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold - Benzinga
- 6 months ago - Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 6 months ago - Cassava Sciences Appoints Dawn C. Bir to the Board of Directors - GlobeNewsWire
- 8 months ago - Filana Therapeutics Transcript: H.C. Wainwright 27th Annual Global Investment Conference - Transcripts
- 9 months ago - Cassava Reports Q2 2025 Financials Results and Provides Business Update - GlobeNewsWire
- 9 months ago - Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer - GlobeNewsWire